Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Science Advisors
Technology
Overview
RAMP™ Drug Innovation Engine
Pipeline
Overview
Risvodetinib (IkT-148009) for Parkinson’s Disease and GI complications
IkT-001Pro for CML
IkT-01427 for PML
Collaborative Programs
Partnering with Inhibikase
Scientific Publications
Clinical Trials
News
Press Releases
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
Careers
Events
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Upcoming Events
Jun 7, 2024 4:00 pm EDT
2024 Annual Meeting of Stockholders
Webcast
Audio
Past Events
Mar 28, 2024 8:00 am EDT
Fourth Quarter and Full Year 2023 Earnings Conference Call
Mar 9, 2024 1:25 pm EDT
2024 AD/PD Meeting
Nov 15, 2023 8:00 am EDT
Third Quarter 2023 Earnings Conference Call
View All Past Events
Email Alerts
Contacts
RSS News Feed